Member Login
Market Reports
 |
|
EXECUTIVE SUMMARY i. Methodology ii. Major Wound Types iii. Wound Dressings a. Market Analysis iv. Wound Cleansing/Debridement Products a. Market Analysis v. Combined Market Analysis Exhibit ES-1: Major Wound Types, by Cause Exhibit ES-2: Exhibit ES-3: Exhibit ES-4: Exhibit ES-5: Exhibit ES-6: Exhibit ES-7: Exhibit ES-8: Exhibit ES-9: Nordic Countries, Wound Dressings, Market Forecast, 2002-2012 Exhibit ES-10: Rest of Exhibit ES-11: Exhibit ES-12: Exhibit ES-13: Exhibit ES-14: Exhibit ES-15: Exhibit ES-16: Exhibit ES-17: Exhibit ES-18: Nordic Countries, Wound Cleansing/Debridement Products, Market Forecast, 2002-2012 Exhibit ES-19: Rest of Exhibit ES-20: Exhibit ES-21: Exhibit ES-22: Exhibit ES-23: Exhibit ES-24: Exhibit ES-25: Exhibit ES-26: Exhibit ES-27: Nordic Countries, Wound Dressings and Wound Cleansing/Debridement Products, Combined Market Forecast, 2002-2012 Exhibit ES-28: Rest of 1. EUROPEAN HEALTHCARE MARKETS 1.1 The European Union 1.1.1 A Common Currency 1.1.2 Regulatory Policies 1.1.3 Reimbursement 1.1.4 Healthcare Spending 1.2 Selected European National Healthcare Profiles 1.2.1 1.2.1.1 Healthcare Organization and Reform 1.2.1.3 Medical Device Reimbursement 1.2.2 1.2.2.1 Healthcare Organization and Reform 1.2.2.3 Medical Device Reimbursement 1.2.3 1.2.3.1 Healthcare Organization and Reform 1.2.3.3 Medical Device Reimbursement 1.2.4 1.2.4.1 Healthcare Organization and Reform 1.2.4.3 Medical Device Reimbursement 1.2.5 1.2.5.1 Healthcare Organization and Reform 1.2.5.3 Medical Device Reimbursement 1.2.6 1.2.6.1 Healthcare Organization and Reform 1.2.6.1.1 1.2.6.1.2 1.2.6.1.3 The 1.2.6.3 Medical Device Reimbursement 1.2.7 Nordic Countries 1.2.7.1 Healthcare Organization and Reform 1.2.7.1.1 1.2.7.1.2 1.2.7.1.3 1.2.7.1.4 1.2.7.3 Medical Device Reimbursement Exhibit 1-1: European Union, Medical Devices Risk Classification System Exhibit 1-2: European Union, Population Statistics Comparison, 1995 and 2005 Exhibit 1-3: Exhibit 1-4: Exhibit 1-5: Exhibit 1-6: Exhibit 1-7: Exhibit 1-8: Exhibit 1-9: Exhibit 1-10: The Exhibit 1-11: Exhibit 1-12: Exhibit 1-13: Exhibit 1-14: 2. CLINICAL ISSUES IN WOUND MANAGEMENT 2.1 Physiology of Wound Closure 2.1.1 Layers of the Skin and Supporting Structures 2.1.1.1 Epidermis 2.1.1.2 Dermis 2.1.1.3 Subcutaneous Tissue 2.1.1.4 Fascia 2.1.1.5 Muscle 2.1.1.6 Bone 2.1.2 Wound Closure Process 2.1.2.1 Hemostasis 2.1.2.2 Inflammation 2.1.2.3 Proliferation 2.1.2.4 Remodeling Phase 2.2 Factors Affecting Wound Closure 2.2.1 Extrinsic Factors 2.2.1.1 Desiccation 2.2.1.2 Hydration 2.2.1.3 Infection 2.2.1.4 Maceration 2.2.1.5 Medications and Other Types of Treatment 2.2.1.6 Necrotic Tissue and Debris 2.2.1.7 Oxygenation 2.2.1.8 Stress 2.2.1.9 Temperature 2.2.1.10 Wound Creation and Depth 2.2.1.11 Wound Closure Techniques 2.2.1.12 Other Extrinsic Factors 2.2.2 Intrinsic Factors 2.2.2.1 Body Build 2.2.2.2 Chronic Illness and Age 2.2.2.3 Nutrition 2.2.3 Complications of Wound Healing 2.2.3.1 Bleeding 2.2.3.2 Scarring 2.3 Major Wound Types 2.3.1 Amputation 2.3.2 Arterial Ulcers 2.3.3 Burns 2.3.4 Diabetic Ulcers 2.3.5 Pressure Ulcers 2.3.6 Surgical Wounds 2.3.7 Traumatic Wounds 2.3.8 Venous Ulcers Exhibit 2-1: Layers of the Skin and Supporting Structures Exhibit 2-2: Phases of the Wound Closure Process Exhibit 2-3: Intrinsic and Extrinsic Factors Affecting Wound Closure Exhibit 2-4: Major Wound Types, by Cause Exhibit 2-5: Stages of Burn Wounds Exhibit 2-6: Stages of Pressure Ulcers Exhibit 2-7: 2005, Surgical Procedure Volumes 3. WOUND DRESSINGS 3.1 Conventional Nonocclusive Wound Dressings 3.1.1 Products 3.1.2 Market Analysis 3.1.3 Competitive Analysis 3.2 Advanced Wound Dressings 3.2.1 Alginate Dressings 3.2.1.1 Products 3.2.1.2 Market Analysis 3.2.1.3 Competitive Analysis 3.2.2 Film Dressings 3.2.2.1 Products 3.2.2.2 Market Analysis 3.2.2.3 Competitive Analysis 3.2.3 Foam Dressings 3.2.3.1 Products 3.2.3.2 Market Analysis 3.2.3.3 Competitive Analysis 3.2.4 Hydrocolloid Dressings 3.2.4.1 Products 3.2.4.2 Market Analysis 3.2.4.3 Competitive Analysis 3.2.5 Amorphous Hydrogels and Hydrogel Dressings 3.2.5.1 Products 3.2.5.2 Market Analysis 3.2.5.3 Competitive Analysis 3.2.6 Nonadherent Wound-Contact Layer Products 3.2.6.1 Products 3.2.6.2 Market Analysis 3.2.6.3 Competitive Analysis 3.2.7 Antimicrobial and Odor Control Dressings 3.2.7.1 Products 3.2.7.2 Market Analysis 3.2.7.3 Competitive Analysis Exhibit 3-1: 2006, Selected Nonocclusive Dressings Exhibit 3-2: Exhibit 3-3: 2005, Exhibit 3-4: 2005, Exhibit 3-5: 2005, Exhibit 3-6: 2005, Exhibit 3-7: 2005, Exhibit 3-8: 2005, Exhibit 3-9: 2005, Exhibit 3-10: 2005, Nordic Countries, Conventional Wound Dressings Market, Share by Supplier Exhibit 3-11: 2005, Rest of Exhibit 3-12: 2006, Selected Alginate Wound Dressings Exhibit 3-13: Exhibit 3-14: 2005, Exhibit 3-15: 2005, Exhibit 3-16: 2005, Exhibit 3-17: 2005, Exhibit 3-18: 2005, Exhibit 3-19: 2005, Exhibit 3-20: 2005, Exhibit 3-21: 2005, Nordic Countries, Alginate Wound Dressings Market, Share by Supplier Exhibit 3-22: 2005, Rest of Exhibit 3-23: 2006, Selected Film Wound Dressings Exhibit 3-24: Exhibit 3-25: 2005, Exhibit 3-26: 2005, Exhibit 3-27: 2005, Exhibit 3-28: 2005, Exhibit 3-29: 2005, Exhibit 3-30: 2005, Exhibit 3-31: 2005, Exhibit 3-32: 2005, Nordic Countries, Film Wound Dressings Market, Share by Supplier Exhibit 3-33: 2005, Rest of Exhibit 3-34: 2006, Selected Foam Wound Dressings Exhibit 3-35: Foam Wound Dressings, Market Forecast, by Country, 2002-2012 Exhibit 3-36: 2005, Exhibit 3-37: 2005, Exhibit 3-38: 2005, Exhibit 3-39: 2005, Exhibit 3-40: 2005, Exhibit 3-41: 2005, Exhibit 3-42: 2005, Exhibit 3-43: 2005, Nordic Countries, Foam Wound Dressings Market, Share by Supplier Exhibit 3-44: 2005, Rest of Exhibit 3-45: 2006, Selected Hydrocolloid Wound Dressings Exhibit 3-46: Exhibit 3-47: 2005, Exhibit 3-48: 2005, Exhibit 3-49: 2005, Exhibit 3-50: 2005, Exhibit 3-51: 2005, Exhibit 3-52: 2005, Exhibit 3-53: 2005, Exhibit 3-54: 2005, Nordic Countries, Hydrocolloid Wound Dressings Market, Share by Supplier Exhibit 3-55: 2005, Rest of Exhibit 3-56: 2006, Selected Hydrogel Wound Dressings Exhibit 3-57: Exhibit 3-58: 2005, Exhibit 3-59: 2005, Exhibit 3-60: 2005, Exhibit 3-61: 2005, Exhibit 3-62: 2005, Exhibit 3-63: 2005, Exhibit 3-64: 2005, Exhibit 3-65: 2005, Nordic Countries, Hydrogel Wound Dressings Market, Share by Supplier Exhibit 3-66: 2005, Rest of Exhibit 3-67: 2006, Selected Nonadherent Wound-Contact Layer Dressings Exhibit 3-68: Exhibit 3-69: 2005, Exhibit 3-70: 2005, Exhibit 3-71: 2005, Exhibit 3-72: 2005, Exhibit 3-73: 2005, Exhibit 3-74: 2005, Exhibit 3-75: 2005, Exhibit 3-76: 2005, Nordic Countries, Nonadherent Wound-Contact Layer Dressings Market, Share by Supplier Exhibit 3-77: 2005, Rest of Exhibit 3-78: 2006, Selected Antimicrobial and Odor Control Dressings Exhibit 3-79: Exhibit 3-80: 2005, Exhibit 3-81: 2005, Exhibit 3-82: 2005, Exhibit 3-83: 2005, Exhibit 3-84: 2005, Exhibit 3-85: 2005, Exhibit 3-86: 2005, Exhibit 3-87: 2005, Nordic Countries, Antimicrobial and Odor Control Dressings Market, Share by Supplier Exhibit 3-88: 2005, Rest of 4. WOUND CLEANSING/DEBRIDEMENT PRODUCTS 4.1 Wound Cleansing Products 4.1.1 Wound Irrigation 4.1.2 Wound Cleansing 4.1.3 Market Analysis 4.1.4 Competitive Analysis 4.2 Wound Debridement Products 4.2.1 Market Analysis 4.2.2 Competitive Analysis Exhibit 4-1: Commonly Used Wound Irrigation Methods Exhibit 4-2: 2006, Selected Wound Cleansers Exhibit 4-3: Exhibit 4-4: 2005, Exhibit 4-5: 2005, Exhibit 4-6: 2005, Exhibit 4-7: 2005, Exhibit 4-8: 2005, Exhibit 4-9: 2005, Exhibit 4-10: 2005, Exhibit 4-11: 2005, Nordic Countries, Wound Cleansing Products Market, Share by Supplier Exhibit 4-12: 2005, Rest of Exhibit 4-13: 2006, Selected Chemical/Enzymatic Wound Debridement Products Exhibit 4-14: Exhibit 4-15: 2005, Exhibit 4-16: 2005, Exhibit 4-17: 2005, Exhibit 4-18: 2005, Exhibit 4-19: 2005, Exhibit 4-20: 2005, United Kingdom, Wound Debridement Products Market, Share by Supplier Exhibit 4-21: 2005, Exhibit 4-22: 2005, Nordic Countries, Wound Debridement Products Market, Share by Supplier Exhibit 4-23: 2005, Rest of 5. COMPANY PROFILES 5.1 3M Health Care, Inc./3M Company 5.2 C.R. Bard, Inc. 5.3 B. Braun Melsungen AG 5.4 BSN medical, Inc. 5.5 Coloplast Group AS 5.6 ConvaTec/Bristol-Myers Squibb Company 5.7 Johnson & Johnson 5.8 Kendall/Tyco International LTD 5.9 Molnlycke Health Care AB 5.10 Pfizer, Inc. 5.11 Smith & Nephew PLC 5.12 Unomedical AS/Nordic Capital AS 5.13 Wyeth *** This is a partial list of companies, for a full listing request it ***
* Single License allows for report sharing within one company location.
Over the past 20 years, dramatic advances have been made in the management of wound patients. These factors have greatly improved the ability of clinicians to overcome many of the previously irresolvable issues associated with the treatment of acute and chronic wounds. In 2005, the European wound dressings and wound cleansing/debridement products market totaled approximately $1.3 billion, with wound dressings accounting for 93% of sales and wound cleansing/debridement products accounting for the remaining 7% of sales. Over the forecast period covered by this report, total sales are expected to increase at a compound annual rate of 5.7%, reaching approximately $1.9 billion in the year 2012.
This 355-page report from Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European wound dressings and wound cleansing/debridement products market. Topics discussed in this report include: an overview of the healthcare markets of France, Germany, Italy, Spain, the United Kingdom, the Benelux countries, and the Nordic countries; an overview of clinical issues in wound management; wound dressings, including alginate dressings, film dressings, foam dressings, hydrocolloid dressing, amorphous hydrogels, nonadherent wound-contact layer products, and antimicrobial/odor control dressings; wound cleansing products; and chemical/ enzymatic wound debridement products.
3M Health Care, Inc./3M Company
C.R. Bard, Inc.
B. Braun Melsungen AG
BSN medical, Inc.
Coloplast Group AS
ConvaTec/Bristol-Myers Squibb Company
Johnson & Johnson
Kendall/Tyco International LTD
Molnlycke Health Care AB
Pfizer, Inc.
Smith & Nephew PLC
Unomedical AS/Nordic Capital AS
Wyeth
+ MORE
** Corporate License allows for report sharing within all company locations.
This report is listed in the following markets:
Biomaterials, Biotechnology and Wound Management